RecruitingPhase 1Phase 2NCT06654193

Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury

Allogeneic Adipose-derived Mesenchymal Stem Cells (MSC) for Acute Kidney Injury After Trauma or Burn

Sponsor

Hope Biosciences LLC

Enrollment

70 participants

Start Date

Feb 1, 2026

Study Type

INTERVENTIONAL

Conditions

Acute Kidney Injury

Summary

This study aims to investigate, through the collection of valid scientific evidence necessary to determine safety and effectiveness, the potential use of Allogeneic Hope Biosciences Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) to prevent progression of trauma-induced Acute Kidney Injury (AKI).

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Allogeneic HB-adMSCs and a drug called Normal Saline for people with acute kidney injury. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAllogeneic HB-adMSCs

Allogeneic HB-adMSCs

DRUGNormal Saline

Sterile Saline Solution

Locations(3)

University of Alabama at Birmingham

Birmingham, Alabama, United States

University of California, San Francisco

San Francisco, California, United States

University of Texas Health Science Center at Houston (UTHealth Houston)

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06654193

Related Trials

Fluid-removal Guided by VeXUS Score With Usual Care in Patients With Acute Kidney Injury After Cardiac Surgery

NCT062517132 locations

Biomarker and Renal Angina Validation to Assess Heart-Kidney Outcomes After Amino Acid Therapy

NCT072125951 location

FST Analysis Supporting Timely Therapy and Risk Assessment Via Clinical Decision Support for Kids

NCT077184641 location

Effect of a Furosemide Stress Test-Guided Strategy on Liberation From Continuous Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury

NCT062299901 location

Clinical Study to Evaluate the Efficacy and Safety of Mesenchymal Stromal Cells (Amimestrocel ) in Patients With Acute Kidney Injury

NCT069547406 locations